Search

everythinglearnresearchcommunity

for

Search:↓

A lotion with Centella asiatica extract reduced hair loss by 41% and increased hair strength without side effects.

The lotion with N1-methylspermidine and Sandalore® effectively reduces hair loss and promotes hair growth.

The supplement reduces hair loss and increases hair thickness in older women.

Men typically shed about 10 hairs in 60 seconds, and this amount doesn't increase with age.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Women with and without hair loss have similar amounts of exogen hairs, so these hairs are not a key factor in hair loss conditions.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The serum increased hair density and was well-tolerated, but didn't affect hair thickness or shedding.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

The modified wash test is better than TrichoScan® for diagnosing hair loss.

The Modified Wash Test is reliable for diagnosing hair loss conditions and determining treatment priority.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

TRICHONEM™ hair wash powder effectively treats dandruff and promotes hair growth.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Understanding hair structure and growth is key for diagnosing hair diseases accurately.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

The document concludes that objective methods are important for diagnosing different types of alopecia and monitoring treatment, and standardizing these techniques is necessary.